Efficacy of divozilimab in the treatment of systemic sclerosis: results of the randomized phase III clinical trial BCD-132-5/LIBERIUS

Authors: L. P. Ananyeva, M. N. Starovoytova, I. Z. Gaydukova, G. V. Lukina, E. V. Zonova, L. V. Eliseeva, G. F. Fatkhullina, D. I. Abdulganieva, D. G. Krechikova, T. V. Kropotina, O. B. Nesmeyanova, I. B. Vinogradova, E. S. Zhugrova, L. V. Ivanova, N. E. Nikulenkova, O. R. Ziganshin, T. V. Plaksina, M. V. Zlobin, Yu. Yu. Grabovetskaya, N. F. Soroka, O. B. Ershova, T. V. Povarova, O. N. Anoshenkova, A. A. Lutsky, A. V. Zinkina-Orikhan, Yu. N. Linkova, E. A. Fokina, A. A. Porozova, A. V. Eremeeva

Source: Современная ревматология, Vol 19, Iss 1, Pp 44-48 (2025)

Subject Terms: divozilimab, systemic sclerosis, systemic scleroderma, Medicine

File Description: electronic resource

Relation: https://mrj.ima-press.net/mrj/article/view/1700; https://doaj.org/toc/1996-7012; https://doaj.org/toc/2310-158X

Access URL: https://doaj.org/article/a2ae60f641cf4b81abfd00e2c0f51740

Difficult-to-treat rheumatoid arthritis: predictors and prevention possibilities (analysis of the Moscow unified register of arthritis data)

Authors: E. V. Zhilyaev, G. V. Lukina, E. N. Koltsova, E. I. Schmidt, K. A. Lytkina, I. V. Pozharov

Source: Klinicist, Vol 18, Iss 4, Pp 27-36 (2025)

Subject Terms: difficult-to-treat rheumatoid arthritis, predictor, tumor necrosis factor inhibitor, etanercept, abatacept, jak kinase inhibitor, rituximab, interleukin-6 inhibitor, cohort study, real clinical practice, Medicine

File Description: electronic resource

Relation: https://klinitsist.abvpress.ru/Klin/article/view/624; https://doaj.org/toc/1818-8338

Access URL: https://doaj.org/article/5d517e4a8cc74c6da22bc47ceb56b4cb

Resolution of the Expert Council 'New approaches to the treatment of axial spondyloarthritis'

Authors: A. M. Lila, V. I. Mazurov, E. L. Nasonov, S. A. Lukyanov, T. V. Dubinina, I. Z. Gaidukova, A. A. Klimenko, S. A. Lapshina, G. V. Lukina, M. A. Korolev, R. O. Dreval, P. I. Pchelnikova, N. V. Shatalova

Source: Современная ревматология, Vol 18, Iss 3, Pp 134-139 (2024)

Subject Terms: axial spondyloarthritis, treatment, seniprutug, Medicine

File Description: electronic resource

Relation: https://mrj.ima-press.net/mrj/article/view/1600; https://doaj.org/toc/1996-7012; https://doaj.org/toc/2310-158X

Access URL: https://doaj.org/article/52801d0c44be476096c6a2e22269a5bb

Immunogenicity and Safety of 13-valent Conjugated Pneumococcal Vaccine in Patients with Rheumatoid Arthritis

Authors: B. T. Batozhargalova, M. P. Kostinov, A. D. Shmitko, G. V. Lukina, D. A. Murtazalieva, E. N. Koltsova, E. V. Zhilyaev

Source: Эпидемиология и вакцинопрофилактика, Vol 23, Iss 1, Pp 77-88 (2024)

Subject Terms: pcv13, vaccination, rheumatoid arthritis, immunogenicity, safety, Epistemology. Theory of knowledge, BD143-237

File Description: electronic resource

Relation: https://www.epidemvac.ru/jour/article/view/1942; https://doaj.org/toc/2073-3046; https://doaj.org/toc/2619-0494

Access URL: https://doaj.org/article/032c0eec629c4b5f87d24d0ec21d57d4

Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations

Authors: T. S. Panevin, E. G. Zotkin, E. A. Troshina, G. V. Lukina

Source: Научно-практическая ревматология, Vol 61, Iss 5, Pp 545-553 (2023)

Subject Terms: rituximab, graves’ disease, diffuse toxic goiter, endocrine ophthalmopathy, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://rsp.mediar-press.net/rsp/article/view/3410; https://doaj.org/toc/1995-4484; https://doaj.org/toc/1995-4492

Access URL: https://doaj.org/article/e8ff66be35b1465cbb631b4ad2812b6b

Predictors of biologic disease modifying antirheumatic drugs withdrawal due to the development of adverse events in patients with rheumatoid arthritis

Authors: E. N. Koltsova, G. V. Lukina, E. I. Schmidt, K. A. Lytkina, E. V. Zhilyaev

Source: Современная ревматология, Vol 16, Iss 6, Pp 26-31 (2022)

Subject Terms: rheumatoid arthritis, biologic disease modifying antirheumatic drugs, targeted immunosuppressive agents, adverse events, infectious complications, Medicine

File Description: electronic resource

Relation: https://mrj.ima-press.net/mrj/article/view/1368; https://doaj.org/toc/1996-7012; https://doaj.org/toc/2310-158X

Access URL: https://doaj.org/article/fc2ba8e360ac476996209d73be23f675

Clinical value of antibodies in inflammatory bowel diseases

Authors: E. N. Aleksandrova, A. A. Novikov, G. V. Lukina, A. I. Parfenov

Source: Терапевтический архив, Vol 93, Iss 2, Pp 228-235 (2021)

Subject Terms: inflammatory bowel disease, crohn’s disease, ulcerative colitis, autoantibodies, antimicrobial antibodies, antibodies to peptide antigens, diagnostic and prognostic value, Medicine

File Description: electronic resource

Relation: https://ter-arkhiv.ru/0040-3660/article/viewFile/64782/47657; https://doaj.org/toc/0040-3660; https://doaj.org/toc/2309-5342

Access URL: https://doaj.org/article/7158cd69ea6a465790c2f5db9d36a84e

Survival of bDMARDs in bionaive patients with rheumatoid arthritis: data from a retrospective 12-month follow-up

Authors: E. S. Aronova, G. V. Lukina, S. I. Glukhova, G. I. Gridneva, A. V. Kudryavtseva

Source: Терапевтический архив, Vol 92, Iss 5, Pp 39-45 (2020)

Subject Terms: biological therapy, drug survival, gene-engineering biological drugs, bdmards, abatacept, tocilizumab, rituximab, infliximab, tumor necrosis factor-a blockers, adverse events, inefficacy, rheumatoid arthritis, Medicine

File Description: electronic resource

Relation: https://ter-arkhiv.ru/0040-3660/article/viewFile/34584/pdf; https://doaj.org/toc/0040-3660; https://doaj.org/toc/2309-5342

Access URL: https://doaj.org/article/1b6c0782d7a84baa8fa1dfeda63e6d08

ANALYSIS OF THE RESULTS OF TOFACITINIB THERAPY IN REAL CLINICAL PRACTICE ACCORDING TO THE ALL-RUSSIAN ARTHRITIS REGISTRY (OREL)

Authors: A. S. Avdeeva, A. S. Misiyuk, A. M. Satybaldyev, G. V. Lukina, V. N. Sorotskaya, E. V. Zhilyaev, A. R. Babaeva, A. A. Baranov, V. I. Mazurov, I. N. Shendrygin, T. S. Salnikova, L. A. Knyazeva, D. G. Krechikova, R. R. Samigullina, I. Z. Gaidukova, D. I. Abdulganieva, I. N. Kushnir, O. N. Anoshenkova, N. A. Lapkina, E. A. Koshkarova, A. M. Lila, E. L. Nasonov

Source: Научно-практическая ревматология, Vol 58, Iss 3, Pp 262-267 (2020)

Subject Terms: rheumatoid arthritis, orel registry, tofacitinib, disease activity, real clinical practice, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://rsp.mediar-press.net/rsp/article/view/2891; https://doaj.org/toc/1995-4484; https://doaj.org/toc/1995-4492

Access URL: https://doaj.org/article/67247c6ef07a4d989d5de9fb24f3f8a0

A very early clinical response to treatment with the Janus kinase inhibitor tofacitinib in patients with active rheumatoid arthritis: the dynamics of pain and central sensitization elements

Authors: A. E. Karateev, E. S. Filatova, E. Yu. Pogozheva, V. N. Amirdzhanova, E. L. Nasonov, A. M. Lila, V. I. Mazurov, A. Yu. De, A. A. Baranov, N. A. Lapkina, G. V. Lukina, N. A. Kiryukhina, S. Yu. Davidyan, T. S. Salnikova, R. R. Samigullina, D. S. Chakieva, I. M. Marusenko, O. V. Semagina, M. Yu. Semchenkova, A. F. Davydova, E. V. Kalinina

Source: Современная ревматология, Vol 14, Iss 2, Pp 69-75 (2020)

Subject Terms: rheumatoid arthritis, chronic pain, central sensitization, tofacitinib, efficacy, safety, Medicine

File Description: electronic resource

Relation: https://mrj.ima-press.net/mrj/article/view/1010; https://doaj.org/toc/1996-7012; https://doaj.org/toc/2310-158X

Access URL: https://doaj.org/article/af84c1d6e4e34c688e41f9ab87acd8f6

Infliximab tolerance in patients with rheumatoid arthritis in real clinical practice

Authors: E. S. Aronova, G. V. Lukina, Ya. A. Sigidin

Source: Научно-практическая ревматология, Vol 58, Iss 1, Pp 31-36 (2020)

Subject Terms: biological therapy, biological agents, infliximab, tumor necrosis factor-а inhibitors, adverse reactions, rheumatoid arthritis, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://rsp.mediar-press.net/rsp/article/view/2840; https://doaj.org/toc/1995-4484; https://doaj.org/toc/1995-4492

Access URL: https://doaj.org/article/aef04e6f076645559a8a473e208046b3

Evaluation of the clinical and anti-destructive effect of an anti-B cell preparation depending on concomitant therapy with basic anti-inflammatory drugs and glucocorticoids in patients with rheumatoid arthritis

Authors: A. V. Kudryavtseva, G. V. Lukina, A. V. Smirnov, S. I. Glukhova

Source: Медицинский совет, Vol 0, Iss 18, Pp 110-117 (2019)

Subject Terms: rheumatoid arthritis, rituximab, dmards, glucocorticoids, clinical effect, bone destruction, Medicine

File Description: electronic resource

Relation: https://www.med-sovet.pro/jour/article/view/5003; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790

Access URL: https://doaj.org/article/18b8b4890967419ebed7d7a35259f5a9

Serum cytokine profile in early and established rheumatoid arthritis

Authors: A. A. Novikov, Е. N. Aleksandrova, G. V. Lukina

Source: Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 393-399 (2019)

Subject Terms: rheumatoid arthritis, pathogenesis, cytokine profile, Medicine

File Description: electronic resource

Relation: https://www.almclinmed.ru/jour/article/view/1114; https://doaj.org/toc/2072-0505; https://doaj.org/toc/2587-9294

Access URL: https://doaj.org/article/767c766233df4635bece203c55c14095

Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up study

Authors: D. V. Bukhanova, M. S. Sergeeva, B. S. Belov, G. M. Tarasova, M. V. Cherkasova, Yu. A. Muraviev, G. V. Lukina, N. V. Demidova

Source: Современная ревматология, Vol 12, Iss 4, Pp 85-88 (2018)

Subject Terms: rheumatoid arthritis, pneumonia, vaccination, pneumococcal vaccine, Medicine

File Description: electronic resource

Relation: https://mrj.ima-press.net/mrj/article/view/866; https://doaj.org/toc/1996-7012; https://doaj.org/toc/2310-158X

Access URL: https://doaj.org/article/5154c521ec0542b68e26fe35bcccb6a7

PROGRESSION OF CAROTID ARTERY ATHEROSCLEROSIS DURING TREATMENT TO TARGET IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

Authors: E. V. Udachkina, D. S. Novikova, T. V. Popkova, I. G. Kirillova, E. I. Markelova, Yu. N. Gorbunova, D. E. Karateev, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina, S. I. Glukhova, A. V. Volkov

Source: Научно-практическая ревматология, Vol 56, Iss 4, Pp 449-455 (2018)

Subject Terms: carotid artery atherosclerosis, duplex scanning of carotid arteries, early rheumatoid arthritis, treat to target strategy, inflammation, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://rsp.mediar-press.net/rsp/article/view/2590; https://doaj.org/toc/1995-4484; https://doaj.org/toc/1995-4492

Access URL: https://doaj.org/article/91c02c5ffd164a379cb6be690fcd330d

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS

Authors: D. V. Bukhanova, В. S. Belov, G. M. Tarasova, Sh. F. Erdes, T. V. Dubinina, G. V. Lukina, M. V. Cherkasova, M. E. Diatroptov

Source: Klinicist, Vol 12, Iss 1, Pp 25-28 (2018)

Subject Terms: rheumatoid arthritis, ankylosing spondylitis, autoimmune diseases, rheumatoid disorders, comorbid infections, comorbidity, influenza, vaccination, influenza vaccine, trivalent split virion influenza vaccine, Medicine

File Description: electronic resource

Relation: https://klinitsist.abvpress.ru/Klin/article/view/337; https://doaj.org/toc/1818-8338

Access URL: https://doaj.org/article/dd5e36a02cdf48009e28f41e68e00704

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases

Authors: D. V. Bukhanova, B. S. Belov, G. M. Tarasova, Sh. Erdes, T. V. Dubinina, G. V. Lukina, N. V. Demidova, A. V. Volkov, N. N. Yudkina, M. V. Cherkasova, M. E. Diatroptov

Source: Медицинский совет, Vol 0, Iss 12, Pp 106-110 (2018)

Subject Terms: rheumatoid arthritis, ankylosing spondylitis, autoimmune diseases, comorbid infections, comorbidity, influenza, vaccination, flu vaccine, Medicine

File Description: electronic resource

Relation: https://www.med-sovet.pro/jour/article/view/2572; https://doaj.org/toc/2079-701X; https://doaj.org/toc/2658-5790

Access URL: https://doaj.org/article/e9c03645fc6a4fd99cc7a9ecca32b23b

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS

Authors: I. G. Kirillova, D. S. Novikova, T. V. Popkova, E. V. Udachkina, E. I. Markelova, A. A. Novikov, Yu. N. Gorbunova, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina

Source: Научно-практическая ревматология, Vol 56, Iss 3, Pp 328-332 (2018)

Subject Terms: early rheumatoid arthritis, remarca, nt-probnp, cardiovascular risk, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://rsp.mediar-press.net/rsp/article/view/2567; https://doaj.org/toc/1995-4484; https://doaj.org/toc/1995-4492

Access URL: https://doaj.org/article/05114a36761c4c3b94a5e4048f24c465

THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Authors: M. A. Borisova, G. V. Lukina, Ya. A. Sigidin, E. L. Luchikhina, D. E. Karateev, A. A. Novikov, E. N. Aleksandrova, M. V. Cherkasova, E. S. Aronova, S. L. Glukhova, E. L. Nasonov

Source: Научно-практическая ревматология, Vol 55, Iss 4, Pp 368-375 (2017)

Subject Terms: abacept, rheumatoid arthritis, biological therapy, cytokines, predictors of the effectiveness of therapy, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://rsp.mediar-press.net/rsp/article/view/2409; https://doaj.org/toc/1995-4484; https://doaj.org/toc/1995-4492

Access URL: https://doaj.org/article/eea8a63e1d194d8db1654ec7fabbc6bb

The effect of tofacitinib on function and quality of life indicators in patients with rheumatoid arthritis resistant to synthetic and biological disease-modifying antirheumatic drugs in real clinical practice: Results of a multicenter observational study

Authors: D. E. Karateev, D. E. Abdulganieva, A. R. Babaeva, A. A. Baranov, L. P. Evstigneeva, O. N. Ivanova, G. V. Lukina, E. L. Luchikhina, V. I. Mazurov, A. S. Misiyuk, O. V. Semagina, A. E. Sizikov, V. N. Sorotskaya

Source: Современная ревматология, Vol 11, Iss 1, Pp 12-18 (2017)

Subject Terms: rheumatoid arthritis, functional ability, quality of life, tofacitinib., Medicine

File Description: electronic resource

Relation: https://mrj.ima-press.net/mrj/article/view/732; https://doaj.org/toc/1996-7012; https://doaj.org/toc/2310-158X

Access URL: https://doaj.org/article/839287e5b05248d6961f1e62357d6a26